Search research articles
Contact Us
Filters
Showing results (41-50 of 238) with videos related to
Page
of 24
Sort By:
Molecular and Cellular Endocrinology
|
May 5, 2010
Pituitary tumours: the sst/D2 receptors as molecular targets
Leo J Hofland, Richard A Feelders, Wouter W de Herder, et al.
Endocrine
|
May 2, 2003
Octreoscan radioreceptor imaging
Aart J van der Lely, Wouter W de Herder, Eric P Krenning, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 26, 2012
[Outpatient surgical treatment of primary hyperparathyroidism]
Tessa M van Ginhoven, Wanda Geilvoet, Wouter W de Herder, et al.
Endocrine-Related Cancer
|
May 10, 2017
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis
Wouter T Zandee, Kimberly Kamp, Roxanne C van Adrichem, et al.
Journal of Neuroendocrinology
|
June 8, 2023
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey
Jorge Hernando, Teodora Kolarova, Chris Verslype, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 13, 2026
Determining Prognosis in Patients With Carcinoid Syndrome: A Retrospective Single-Center Cohort Study
Merijn C F Mulders, Celine F Maas, Richard A Feelders, et al.
European Journal of Endocrinology
|
May 13, 2022
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients
Julie Refardt, Tessa Brabander, Noémie S Minczeles, et al.
Cancers
|
December 11, 2022
A Clinical Guide to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients
Morticia N Becx, Noémie S Minczeles, Tessa Brabander, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]
|
December 16, 2021
Matching-adjusted indirect treatment comparison of [<sup>177</sup>Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [<sup>177</sup>Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
Mohid S Khan, Elaine Stamp, Cormac Sammon, et al.
Clinical Endocrinology
|
September 14, 2012
The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET)
George Kanakis, Kimberly Kamp, Konstantinos Tsiveriotis, et al.
Page
of 24
Search research articles
Search
Showing results (41-50 of 238) with videos related to
Sort By:
Page
of 24
Molecular and Cellular Endocrinology
|
May 5, 2010
Pituitary tumours: the sst/D2 receptors as molecular targets
Leo J Hofland, Richard A Feelders, Wouter W de Herder, et al.
Endocrine
|
May 2, 2003
Octreoscan radioreceptor imaging
Aart J van der Lely, Wouter W de Herder, Eric P Krenning, et al.
Nederlands Tijdschrift Voor Geneeskunde
|
June 26, 2012
[Outpatient surgical treatment of primary hyperparathyroidism]
Tessa M van Ginhoven, Wanda Geilvoet, Wouter W de Herder, et al.
Endocrine-Related Cancer
|
May 10, 2017
Effect of hormone secretory syndromes on neuroendocrine tumor prognosis
Wouter T Zandee, Kimberly Kamp, Roxanne C van Adrichem, et al.
Journal of Neuroendocrinology
|
June 8, 2023
Satisfaction with injection experience of patients with neuroendocrine tumors enrolled on lanreotide autogel patient support programs: Results from the international HomeLAN survey
Jorge Hernando, Teodora Kolarova, Chris Verslype, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 13, 2026
Determining Prognosis in Patients With Carcinoid Syndrome: A Retrospective Single-Center Cohort Study
Merijn C F Mulders, Celine F Maas, Richard A Feelders, et al.
European Journal of Endocrinology
|
May 13, 2022
Prognostic value of dysnatremia for survival in neuroendocrine neoplasm patients
Julie Refardt, Tessa Brabander, Noémie S Minczeles, et al.
Cancers
|
December 11, 2022
A Clinical Guide to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE in Neuroendocrine Tumor Patients
Morticia N Becx, Noémie S Minczeles, Tessa Brabander, et al.
EJC Supplements : EJC : Official Journal of EORTC, European Organization for Research and Treatment of Cancer ... [Et Al.]
|
December 16, 2021
Matching-adjusted indirect treatment comparison of [<sup>177</sup>Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [<sup>177</sup>Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours
Mohid S Khan, Elaine Stamp, Cormac Sammon, et al.
Clinical Endocrinology
|
September 14, 2012
The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET)
George Kanakis, Kimberly Kamp, Konstantinos Tsiveriotis, et al.
Page
of 24